Tatsuhiro Sato

5PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 19, 2026
New anti-mesothelioma compounds, paramyfurans and paramylactone, produced by Paramyrothecium sp. BF-1049.

|Mar 06, 2026
Enhanced nuclear export caused by O-GlcNAcylation of nucleoporins is a potential therapeutic target in mesothelioma.

Satomi Mukai, Tatsuhiro Sato, Yasuhiro Kamei

|Dec 30, 2025
Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma Cells.

Tatsuhiro Sato, Ikue Hasegawa, Haruna Ikeda

|Dec 17, 2024
TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.

Ken Akao, Tatsuhiro Sato, Emi Mishiro-Sato

|May 11, 2023
Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.

Tatsuhiro Sato, Ken Akao, Ayuko Sato

Pageof 1

Frequent Collaborators

2 joint publications

Emi Mishiro-Sato

2 joint publications

Satomi Mukai

2 joint publications

Yoshitaka Sekido

2 joint publications

Taichi Ohshiro